Biotech Licenses Intellectual Property (IP) to an Early-Stage Drug Compound

Biotech licenses intellectual property (IP) to an early-stage drug compound to Pharma. Biotech also provides research and development (R&D) services as part of the arrangement. Biotech is the only vendor able to provide the R&D services based on its specialised knowledge of the technology. How is this arrangement defined?

A) licence
B) distinct licence
C) non distinct licence
D) patent